TP53 and cancer: To further explore the clinical implication of CYP4F12 in HNSC, we first classified patients in the TCGA HNSC dataset with different clinicopathologic characteristics, including age, gender, race, tumor grade, individual cancer stage, HPV status, TP53 mutation status and nodal metastasis status.